Although not a predictor of CIN, the circulating serum galectin-1 level is an independent prognostic marker for subsequent renal function decline in patients undergoing CAG, irrespective of diabetes. This evidence concerns the gene LGALS1 and cervical squamous intraepithelial neoplasia.